DURAJECT Trademark

Trademark Overview

On Wednesday, February 21, 2024, a trademark application was filed for DURAJECT with the United States Patent and Trademark Office. The USPTO has given the DURAJECT trademark a serial number of 98414251. The federal status of this trademark filing is EXAMINER STATEMENT - MAILED as of Tuesday, October 28, 2025. This trademark is owned by EyePoint Pharmaceuticals US, Inc.. The DURAJECT trademark is filed in the Medical Instrument Products category with the following description:

Medical and surgical apparatus and instruments for use in ophthalmic procedures
duraject

General Information

Serial Number98414251
Word MarkDURAJECT
Filing DateWednesday, February 21, 2024
Status757 - EXAMINER STATEMENT - MAILED
Status DateTuesday, October 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical and surgical apparatus and instruments for use in ophthalmic procedures

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, February 21, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEyePoint Pharmaceuticals US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Wednesday, February 21, 2024NEW APPLICATION ENTERED
Wednesday, June 26, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 11, 2024ASSIGNED TO EXAMINER
Wednesday, September 18, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 18, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 4, 2024FINAL REFUSAL WRITTEN
Monday, November 4, 2024FINAL REFUSAL E-MAILED
Monday, November 4, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 27, 2024EXPARTE APPEAL RECEIVED AT TTAB
Friday, December 27, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, December 27, 2024EX PARTE APPEAL-INSTITUTED
Friday, December 27, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 21, 2025ASSIGNED TO LIE
Tuesday, January 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 21, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 18, 2025ACTION CONTINUING FINAL - COMPLETED
Tuesday, February 18, 2025ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, February 18, 2025NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Thursday, May 1, 2025EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Wednesday, June 11, 2025EXPARTE APPEAL TERMINATED
Wednesday, June 11, 2025ABANDONMENT - AFTER EX PARTE APPEAL
Thursday, June 12, 2025ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Thursday, August 28, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, October 28, 2025EXAMINERS STATEMENT - COMPLETED
Tuesday, October 28, 2025EXAMINERS STATEMENT E-MAILED
Tuesday, October 28, 2025NOTIFICATION OF EXAMINERS STATEMENT E-MAILED

Related Keywords

duraject ophthalmic procedures instruments apparatus surgical medical